Q1 2025 Holdings
Filed 2025-05-15 | 91 holdings | $843.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insulet Corp(PODD) | COM | 45784P101 | $34.3M | 130,514 | 4.1% |
| CVS Health Corp(CVS) | COM | 126650100 | $33.7M | 496,736 | 4.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $32.4M | 39,191 | 3.8% |
| Stryker Corporation(SYK) | COM | 863667101 | $28.9M | 77,690 | 3.4% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $28.7M | 213,418 | 3.4% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $27.6M | 120,283 | 3.3% |
| Cooper COS Inc(COO) | COM | 216648501 | $26.4M | 312,650 | 3.1% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $26.3M | 50,213 | 3.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $24.5M | 218,950 | 2.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $22.8M | 225,990 | 2.7% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $22.7M | 200,500 | 2.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $19.6M | 277,252 | 2.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $18.6M | 168,382 | 2.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $18.6M | 68,938 | 2.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $17.1M | 954,071 | 2.0% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $16.9M | 762,621 | 2.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $16.5M | 260,421 | 2.0% |
| Rxsight Inc(RXST) | COM | 78349D107 | $15.9M | 631,238 | 1.9% |
| Cvrx Inc(CVRX) | COM | 126638105 | $15.0M | 1,229,522 | 1.8% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $14.9M | 22,101 | 1.8% |
| Revvity Inc(RVTY) | COM | 714046109 | $14.8M | 139,557 | 1.8% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $14.6M | 200,819 | 1.7% |
| Qiagen NV(QGEN) | COM SHS | N72482206 | $14.4M | 359,644 | 1.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $14.3M | 1,064,506 | 1.7% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $14.3M | 280,314 | 1.7% |
| Danaher Corporation(DHR) | COM | 235851102 | $13.0M | 63,250 | 1.5% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $12.5M | 2,493,836 | 1.5% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $11.0M | 304,244 | 1.3% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $10.6M | 62,593 | 1.3% |
| Axogen Inc(AXGN) | COM | 05463X106 | $9.9M | 536,832 | 1.2% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $9.8M | 1,780,454 | 1.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $9.5M | 1,215,629 | 1.1% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $9.5M | 481,470 | 1.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $9.4M | 425,407 | 1.1% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $9.3M | 950,399 | 1.1% |
| Dexcom Inc(DXCM) | COM | 252131107 | $8.9M | 130,367 | 1.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $8.7M | 753,752 | 1.0% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $8.3M | 1,043,162 | 1.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $7.8M | 109,988 | 0.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $7.5M | 1,000,562 | 0.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.3M | 594,987 | 0.9% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $7.0M | 105,000 | 0.8% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $7.0M | 350,551 | 0.8% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $6.6M | 166,871 | 0.8% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $6.4M | 183,678 | 0.8% |
| Treace MED Concepts Inc(TMCI) | COM | 89455T109 | $6.0M | 713,539 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $5.9M | 174,576 | 0.7% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $5.4M | 93,500 | 0.6% |
| Resmed Inc(RMD) | COM | 761152107 | $5.1M | 22,622 | 0.6% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $4.9M | 166,278 | 0.6% |